Steven E. Gryn

1.8k total citations
13 papers, 212 citations indexed

About

Steven E. Gryn is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steven E. Gryn has authored 13 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pharmacology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steven E. Gryn's work include Lipoproteins and Cardiovascular Health (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Steven E. Gryn is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Steven E. Gryn collaborates with scholars based in Canada and United States. Steven E. Gryn's co-authors include Robert A. Hegele, Richard B. Kim, Jeffrey Alfonsi, George K. Dresser, Wendy A. Teft, Rommel G. Tirona, Ute I. Schwarz, Allan C. Skanes, Anthony Tang and Daniel J. Lizotte and has published in prestigious journals such as Journal of the American Geriatrics Society, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

Steven E. Gryn

12 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven E. Gryn Canada	9	95	71	44	38	25	13	212
Quince Gibson United States	6	140 1.5×	73 1.0×	49 1.1×	60 1.6×	41 1.6×	6	264
Payman Shahabi Iran	10	63 0.7×	55 0.8×	62 1.4×	44 1.2×	40 1.6×	26	305
Anita Hanson United Kingdom	6	71 0.7×	116 1.6×	126 2.9×	45 1.2×	42 1.7×	9	323
Jeffrey Rollo United States	8	153 1.6×	37 0.5×	144 3.3×	53 1.4×	56 2.2×	14	345
Chrissa P. Mower United States	7	99 1.0×	51 0.7×	159 3.6×	63 1.7×	79 3.2×	8	362
Marta Tomás Spain	6	244 2.6×	118 1.7×	38 0.9×	64 1.7×	102 4.1×	22	401
Łukasz Wołowiec Poland	11	112 1.2×	72 1.0×	9 0.2×	16 0.4×	59 2.4×	34	310
Chandrashekhar K. Ponde India	10	79 0.8×	86 1.2×	30 0.7×	19 0.5×	49 2.0×	27	217
Joanna Banach Poland	10	125 1.3×	70 1.0×	8 0.2×	15 0.4×	43 1.7×	29	278
Т. В. Вавилова Russia	6	72 0.8×	18 0.3×	25 0.6×	10 0.3×	46 1.8×	89	205

Countries citing papers authored by Steven E. Gryn

Since Specialization

Citations

This map shows the geographic impact of Steven E. Gryn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Gryn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Gryn more than expected).

Fields of papers citing papers by Steven E. Gryn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Gryn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Gryn. The network helps show where Steven E. Gryn may publish in the future.

Co-authorship network of co-authors of Steven E. Gryn

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Gryn. A scholar is included among the top collaborators of Steven E. Gryn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Gryn. Steven E. Gryn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gryn, Steven E., et al.. (2024). SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report. British Journal of Clinical Pharmacology. 91(1). 232–235. 1 indexed citations

Kim, Richard, et al.. (2024). Allopurinol hypersensitivity syndrome. Canadian Urological Association Journal. 18(5). E167–E172. 4 indexed citations

Gryn, Steven E., George K. Dresser, Jeffrey Alfonsi, et al.. (2019). Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation. Journal of the American Geriatrics Society. 67(9). 1902–1906. 15 indexed citations

Tang, Anthony, Steven E. Gryn, Peter Leong‐Sit, et al.. (2017). Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care. Canadian Journal of Cardiology. 33(8). 1036–1043. 49 indexed citations

Teft, Wendy A., et al.. (2017). Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol. Clinical Pharmacology & Therapeutics. 104(3). 525–533. 7 indexed citations

Hegele, Robert A., et al.. (2017). Statin therapy: time for a precision medicine approach?. Expert Review of Precision Medicine and Drug Development. 2(4). 187–192.

Gryn, Steven E. & Robert A. Hegele. (2016). New oral agents for treating dyslipidemia. Current Opinion in Lipidology. 27(6). 579–584. 8 indexed citations

Alfonsi, Jeffrey, Robert A. Hegele, & Steven E. Gryn. (2016). Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?. Current Atherosclerosis Reports. 18(5). 24–24. 22 indexed citations

Gryn, Steven E. & Robert A. Hegele. (2015). Novel therapeutics in hypertriglyceridemia. Current Opinion in Lipidology. 26(6). 484–491. 32 indexed citations

10.

Gryn, Steven E. & Robert A. Hegele. (2015). Ezetimibe plus simvastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy. 16(8). 1255–1262. 17 indexed citations

11.

Woolsey, Sarah, Melanie Beaton, Yun‐Hee Choi, et al.. (2015). Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects. Basic & Clinical Pharmacology & Toxicology. 118(4). 284–291. 27 indexed citations

12.

Gryn, Steven E., Wendy A. Teft, & Richard B. Kim. (2014). Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohort. Pharmacogenetics and Genomics. 24(7). 367–369. 11 indexed citations

13.

Gryn, Steven E. & Robert A. Hegele. (2014). Pharmacogenomics, Lipid Disorders, and Treatment Options. Clinical Pharmacology & Therapeutics. 96(1). 36–47. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact